Literature DB >> 16118408

Direct hepatotoxic effect of KC chemokine in the liver without infiltration of neutrophils.

Lela Stefanovic1, David A Brenner, Branko Stefanovic.   

Abstract

KC is a mouse homolog of human chemokine gro-alpha (CXCL1), expression of which is increased in liver diseases. We show that activated, but not quiescent, hepatic stellate cells (HSCs) express KC. Hepatic stellate cells constitutively express the KC receptor, CXCR2. Addition of recombinant KC to HSCs undergoing activation in culture increases secretion and processing of Type I collagen. Overexpression of endogenous KC in the mouse liver could be achieved by an intraperitoneal injection of CCl(4), followed after 24 hrs by an injection of recombinant KC into circulation. This protocol resulted in about a 14-fold increase in concentration of KC protein in the liver. Overexpression of KC was associated with upregulation of the mRNA for CXCR2 and MIP-2 and with necrosis and increased synthesis of Type I collagen. This suggests that KC has a direct hepatotoxic effect, which led to a massive liver necrosis after 48 hrs. No accumulation of neutrophils was seen in the livers as judged by histology and reverse transcriptase-polymerase chain reaction analysis of myeloperoxidase mRNA. Autostimulation of KC and CXCR2 expression by recombinant KC protein in the mice with preexisting liver injury indicates a positive feedback regulation. Such regulation and direct hepatotoxicity of KC with increased collagen synthesis represent novel findings about the role of KC/ gro-alpha in liver pathology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16118408     DOI: 10.1177/153537020523000809

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  30 in total

Review 1.  Functional role of chemokines in liver disease models.

Authors:  Hacer Sahin; Christian Trautwein; Hermann E Wasmuth
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-26       Impact factor: 46.802

2.  Short- or long-term high-fat diet feeding plus acute ethanol binge synergistically induce acute liver injury in mice: an important role for CXCL1.

Authors:  Binxia Chang; Ming-Jiang Xu; Zhou Zhou; Yan Cai; Man Li; Wei Wang; Dechun Feng; Adeline Bertola; Hua Wang; George Kunos; Bin Gao
Journal:  Hepatology       Date:  2015-07-03       Impact factor: 17.425

3.  CXC receptor-2 knockout genotype increases X-linked inhibitor of apoptosis protein and protects mice from acetaminophen hepatotoxicity.

Authors:  Bin Hu; Lisa M Colletti
Journal:  Hepatology       Date:  2010-08       Impact factor: 17.425

4.  Development and characterization of a rat model of nonpenetrating liver trauma.

Authors:  Jennifer M Cox; John E Kalns
Journal:  Comp Med       Date:  2010-06       Impact factor: 0.982

5.  Cell-specific regulatory effects of CXCR2 on cholestatic liver injury.

Authors:  Takanori Konishi; Rebecca M Schuster; Holly S Goetzman; Charles C Caldwell; Alex B Lentsch
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-10-11       Impact factor: 4.052

6.  CCR1 and CCR5 promote hepatic fibrosis in mice.

Authors:  Ekihiro Seki; Samuele De Minicis; Geum-Youn Gwak; Johannes Kluwe; Sayaka Inokuchi; Christina A Bursill; Josep M Llovet; David A Brenner; Robert F Schwabe
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

7.  Invariant natural killer T cells suppress the neutrophil inflammatory response in a mouse model of cholestatic liver damage.

Authors:  Philip Wintermeyer; Chao-Wen Cheng; Stephan Gehring; Beth L Hoffman; Martin Holub; Laurent Brossay; Stephen H Gregory
Journal:  Gastroenterology       Date:  2008-11-01       Impact factor: 22.682

8.  Role of cytokine receptor-like factor 1 in hepatic stellate cells and fibrosis.

Authors:  Lela Stefanovic; Branko Stefanovic
Journal:  World J Hepatol       Date:  2012-12-27

9.  Hepatocyte signaling through CXC chemokine receptor-2 is detrimental to liver recovery after ischemia/reperfusion in mice.

Authors:  Satoshi Kuboki; Thomas Shin; Nadine Huber; Thorsten Eismann; Elizabeth Galloway; Rebecca Schuster; John Blanchard; Michael J Edwards; Alex B Lentsch
Journal:  Hepatology       Date:  2008-10       Impact factor: 17.425

10.  IP-10 protects while MIP-2 promotes experimental anesthetic hapten - induced hepatitis.

Authors:  Dolores B Njoku; Zhaoxia Li; Jenelle L Mellerson; Rajni Sharma; Monica V Talor; Nicole Barat; Noel R Rose
Journal:  J Autoimmun       Date:  2009-01-07       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.